{"id":811,"date":"2017-07-19T13:33:33","date_gmt":"2017-07-19T13:33:33","guid":{"rendered":"http:\/\/vallis.pt\/uncategorized\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/"},"modified":"2022-09-27T09:18:31","modified_gmt":"2022-09-27T09:18:31","slug":"vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment","status":"publish","type":"post","link":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/","title":{"rendered":"Vallis Capital Partners announces a full exit on CGC Genetics investment"},"content":{"rendered":"<p>Vallis Capital Partners announces that it has reached an agreement to sell CGC Genetics, a leading Medical Genetics Laboratory company serving customers in more than 65 countries, for an undisclosed amount to Unilabs, a Geneva based company.<\/p>\n<p>CGC Genetics has grown to become one of the most advanced European Medical Genetics Laboratory providers, serving customers globally. The company is a reference for Medical Genetics testing, offering a full service of Medical Genetic testing solutions for its customers.<\/p>\n<p>Jos Lamers, CEO of Unilabs said: \u201cCGC has made an impressive journey to build its position as a pivotal player in the Medical Genetic Laboratory markets, with a worldwide footprint. This operation reflects our strategic focus on reinforcing Unilabs\u2019 Reference and Special Testing Portfolio. We look forward to welcoming CGC Genetics into the Unilabs family.\u201d<\/p>\n<p>Eduardo Rocha, CEO of Vallis Capital Partners added: \u201cWe are very proud to have been part of the CGC Genetics success story since our Fund Vallis Sustainable Investments I invested in the company in 2014. Our chief strategic goal was to leverage the exceptional skill set of CGC Genetics which combined with the investment in state-of-the-art technology was the foundation for a growth cycle through international expansion. We are now confident that CGC Genetics will continue to thrive in a new growth cycle within the Unilabs environment.\u201d<\/p>\n<p>Prof. Purifica\u00e7\u00e3o Tavares, CEO of CGC Genetics commented: \u201cWe believe we have found a true strategic partner in Unilabs, and I would like to thank Vallis Capital Partners for helping CGC Genetics getting to the next level. Within Unilabs we have a tremendous opportunity to accelerate our growth via the exchange of best practices and the support of an internationally recognised brand and contribute to expanding Unilabs\u2019 capabilities for the benefit of all it\u2019s customers.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vallis Capital Partners announces that it has reached an agreement to sell CGC Genetics, a leading Medical Genetics Laboratory company serving customers in more than 65 countries, for an undisclosed amount to Unilabs, a Geneva based company. CGC Genetics has grown to become one of the most advanced European Medical Genetics Laboratory providers, serving customers [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":704,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[],"class_list":["post-811","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vallis Capital Partners announces a full exit on CGC Genetics investment - Vallis Capital Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vallis Capital Partners announces a full exit on CGC Genetics investment - Vallis Capital Partners\" \/>\n<meta property=\"og:description\" content=\"Vallis Capital Partners announces that it has reached an agreement to sell CGC Genetics, a leading Medical Genetics Laboratory company serving customers in more than 65 countries, for an undisclosed amount to Unilabs, a Geneva based company. CGC Genetics has grown to become one of the most advanced European Medical Genetics Laboratory providers, serving customers [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/\" \/>\n<meta property=\"og:site_name\" content=\"Vallis Capital Partners\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-19T13:33:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-27T09:18:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/10\/at-laboratory-2021-09-24-03-16-40-utc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1008\" \/>\n\t<meta property=\"og:image:height\" content=\"672\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gest\u00e3o Vallis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gest\u00e3o Vallis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/\"},\"author\":{\"name\":\"Gest\u00e3o Vallis\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#\\\/schema\\\/person\\\/f966934c80caeb0ba208e7cadd02a3db\"},\"headline\":\"Vallis Capital Partners announces a full exit on CGC Genetics investment\",\"datePublished\":\"2017-07-19T13:33:33+00:00\",\"dateModified\":\"2022-09-27T09:18:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/\"},\"wordCount\":305,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/at-laboratory-2021-09-24-03-16-40-utc.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/\",\"url\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/\",\"name\":\"Vallis Capital Partners announces a full exit on CGC Genetics investment - Vallis Capital Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/at-laboratory-2021-09-24-03-16-40-utc.jpg\",\"datePublished\":\"2017-07-19T13:33:33+00:00\",\"dateModified\":\"2022-09-27T09:18:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/#primaryimage\",\"url\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/at-laboratory-2021-09-24-03-16-40-utc.jpg\",\"contentUrl\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2021\\\/10\\\/at-laboratory-2021-09-24-03-16-40-utc.jpg\",\"width\":1008,\"height\":672},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/en\\\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/vallis.pt\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vallis Capital Partners announces a full exit on CGC Genetics investment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#website\",\"url\":\"https:\\\/\\\/vallis.pt\\\/\",\"name\":\"VALLIS Capital Partners\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vallis.pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#organization\",\"name\":\"VALLIS Capital Partners\",\"alternateName\":\"Gestora de Fundos Independente, focada exclusivamente em Capital de Risco Private Equity\",\"url\":\"https:\\\/\\\/vallis.pt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/cropped-favicon-vallis.png\",\"contentUrl\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/cropped-favicon-vallis.png\",\"width\":512,\"height\":512,\"caption\":\"VALLIS Capital Partners\"},\"image\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/valliscapitalpartners\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#\\\/schema\\\/person\\\/f966934c80caeb0ba208e7cadd02a3db\",\"name\":\"Gest\u00e3o Vallis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g\",\"caption\":\"Gest\u00e3o Vallis\"},\"url\":\"https:\\\/\\\/vallis.pt\\\/en\\\/author\\\/vallis\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vallis Capital Partners announces a full exit on CGC Genetics investment - Vallis Capital Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/","og_locale":"en_US","og_type":"article","og_title":"Vallis Capital Partners announces a full exit on CGC Genetics investment - Vallis Capital Partners","og_description":"Vallis Capital Partners announces that it has reached an agreement to sell CGC Genetics, a leading Medical Genetics Laboratory company serving customers in more than 65 countries, for an undisclosed amount to Unilabs, a Geneva based company. CGC Genetics has grown to become one of the most advanced European Medical Genetics Laboratory providers, serving customers [&hellip;]","og_url":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/","og_site_name":"Vallis Capital Partners","article_published_time":"2017-07-19T13:33:33+00:00","article_modified_time":"2022-09-27T09:18:31+00:00","og_image":[{"width":1008,"height":672,"url":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/10\/at-laboratory-2021-09-24-03-16-40-utc.jpg","type":"image\/jpeg"}],"author":"Gest\u00e3o Vallis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gest\u00e3o Vallis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/#article","isPartOf":{"@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/"},"author":{"name":"Gest\u00e3o Vallis","@id":"https:\/\/vallis.pt\/#\/schema\/person\/f966934c80caeb0ba208e7cadd02a3db"},"headline":"Vallis Capital Partners announces a full exit on CGC Genetics investment","datePublished":"2017-07-19T13:33:33+00:00","dateModified":"2022-09-27T09:18:31+00:00","mainEntityOfPage":{"@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/"},"wordCount":305,"commentCount":0,"publisher":{"@id":"https:\/\/vallis.pt\/#organization"},"image":{"@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/#primaryimage"},"thumbnailUrl":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/10\/at-laboratory-2021-09-24-03-16-40-utc.jpg","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/","url":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/","name":"Vallis Capital Partners announces a full exit on CGC Genetics investment - Vallis Capital Partners","isPartOf":{"@id":"https:\/\/vallis.pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/#primaryimage"},"image":{"@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/#primaryimage"},"thumbnailUrl":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/10\/at-laboratory-2021-09-24-03-16-40-utc.jpg","datePublished":"2017-07-19T13:33:33+00:00","dateModified":"2022-09-27T09:18:31+00:00","breadcrumb":{"@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/#primaryimage","url":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/10\/at-laboratory-2021-09-24-03-16-40-utc.jpg","contentUrl":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/10\/at-laboratory-2021-09-24-03-16-40-utc.jpg","width":1008,"height":672},{"@type":"BreadcrumbList","@id":"https:\/\/vallis.pt\/en\/vallis-capital-partners-announces-a-full-exit-on-cgc-genetics-investment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/vallis.pt\/en\/"},{"@type":"ListItem","position":2,"name":"Vallis Capital Partners announces a full exit on CGC Genetics investment"}]},{"@type":"WebSite","@id":"https:\/\/vallis.pt\/#website","url":"https:\/\/vallis.pt\/","name":"VALLIS Capital Partners","description":"","publisher":{"@id":"https:\/\/vallis.pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vallis.pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/vallis.pt\/#organization","name":"VALLIS Capital Partners","alternateName":"Gestora de Fundos Independente, focada exclusivamente em Capital de Risco Private Equity","url":"https:\/\/vallis.pt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vallis.pt\/#\/schema\/logo\/image\/","url":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/12\/cropped-favicon-vallis.png","contentUrl":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/12\/cropped-favicon-vallis.png","width":512,"height":512,"caption":"VALLIS Capital Partners"},"image":{"@id":"https:\/\/vallis.pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/valliscapitalpartners\/"]},{"@type":"Person","@id":"https:\/\/vallis.pt\/#\/schema\/person\/f966934c80caeb0ba208e7cadd02a3db","name":"Gest\u00e3o Vallis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g","caption":"Gest\u00e3o Vallis"},"url":"https:\/\/vallis.pt\/en\/author\/vallis\/"}]}},"_links":{"self":[{"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/posts\/811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/comments?post=811"}],"version-history":[{"count":0,"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/posts\/811\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/media\/704"}],"wp:attachment":[{"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/media?parent=811"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/categories?post=811"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vallis.pt\/en\/wp-json\/wp\/v2\/tags?post=811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}